Bogdan Procopet

Bogdan Procopet

Auto-generated profile, based on publicly available information

Bogdan Procopet

Gastroenterology Clinic, “Prof. Dr. Octavian Fodor” Regional Institute of Gastroenterology and Hepatology, 400162 Cluj-Napoca, Romania

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2020 in Journal of Hepatology
Verified
Journal Article
Open access
JTJonel Trebicka
Jonel Trebicka
WGW Gu
W Gu
LIL Ibáñez-Samaniego
L Ibáñez-Samaniego
VHV Hernández-Gea
V Hernández-Gea
CPC Pitarch
C Pitarch
ICInternational Variceal Bleeding Observational Study Group and Baveno Cooperation
International Variceal Bleeding Observational Study Group and Baveno Cooperation
The relationship between acute-on-chronic liver failure (ACLF) and acute variceal bleeding (AVB) is poorly understood. Specifically, prevalence and prognosis of ACLF in AVB is unclear, while the role of transjugular intrahepatic porto-systemic shunt (TIPS) in the management in ACLF patients has not been described to date. A multicenter, international, observational study was conducted including 2138 patients from 34 centers between 2011 and 2015. ACLF was defined and graded according to the EASL-CLIF consortium definition. Placement of pre-emptive TIPS (pTIPS) was based on individual center policy. Patients were followed up to one year, until death or liver transplantation. Cox regression model and competing risk models (Gray's test) were used to identify independent predictors of rebleeding or mortality. At admission, 380/2138 (17.8%) patients had ACLF according to EASL-CLIF criteria (grade-I:38.7%; II:39.2%; III:22.1%). Forty-two day rebleeding rate (19% vs. 10%; p<0.001) and mortality (47% vs. 10%; p<0.001) were higher in patients with ACLF and increased with ACLF grades. Of note, presence of ACLF was independently associated with rebleeding and mortality. pTIPS placement improved survival in ACLF patients at 42 days and one year. This effect was also observed in propensity score matching analysis of 44 ACLF patients without pTIPS and 22 ACLF patients with pTIPS. This large multi-center international real-life study identified ACLF as at admission an independent predictor of rebleeding and mortality in AVB. Moreover, pTIPS improves survival in patients with ACLF and AVB. Therefore, pTIPS may be considered in ACLF patients with AVB, although the presented data need to be independently validated.

2 September 2022 in Journal of Hepatology
Verified
Journal Article
Closed access
ABAnna Baiges
Anna Baiges
BPBogdan Procopet
Bogdan Procopet
GSGilberto Silva-Junior
Gilberto Silva-Junior
ELElba Llop
Elba Llop
LTLuis Tellez
Luis Tellez
JGJuan Carlos García-Pagán
Juan Carlos García-Pagán

14 June 2020 in World Journal of Gastroenterology
Verified
Journal Article
Open access
ONOana Nicoară-Farcău
Oana Nicoară-Farcău
IRIoana Rusu
Ioana Rusu
HSHoria Stefănescu
Horia Stefănescu
MTMarcel Tanțău
Marcel Tanțău
RBRadu Ion Badea
Radu Ion Badea
BPBogdan Procopeț
Bogdan Procopeț
Diagnostic challenges in non-cirrhotic portal hypertension - porto sinusoidal vascular disease

1 December 2019 in Digestive and Liver Disease
Verified
Journal Article
Closed access
PFPetra Fischer
Petra Fischer
CGCrina Grigoras
Crina Grigoras
ABAnca Bugariu
Anca Bugariu
ONOana Nicoara-Farcau
Oana Nicoara-Farcau
HSHoria Stefanescu
Horia Stefanescu
BPBogdan Procopet
Bogdan Procopet

19 February 2023 in Diagnostics
Verified
Journal Article
Open access
PDF file
MTMadalina-Gabriela Taru
Madalina-Gabriela Taru
LNLidia Neamti
Lidia Neamti
VTVlad Taru
Vlad Taru
Lucia Maria ProcopciucLucia Maria Procopciuc
Lucia Maria Procopciuc
BPBogdan Procopet
Bogdan Procopet
Monica Lupsor-PlatonMonica Lupsor-Platon
Monica Lupsor-Platon
Non-alcoholic fatty liver disease (NAFLD), and its progressive form, non-alcoholic steatohepatitis (NASH), represent, nowadays, real challenges for the healthcare system. Liver fibrosis is the most important prognostic factor for NAFLD, and advanced fibrosis is associated with higher liver-related mortality rates. Therefore, the key issues in NAFLD are the differentiation of NASH from simple steatosis and identification of advanced hepatic fibrosis. We critically reviewed the ultrasound (US) elastography techniques for the quantitative characterization of fibrosis, steatosis, and inflammation in NAFLD and NASH, with a specific focus on how to differentiate advanced fibrosis in adult patients. Vibration-controlled transient elastography (VCTE) is still the most utilized and validated elastography method for liver fibrosis assessment. The recently developed point shear wave elastography (pSWE) and two-dimensional shear wave elastography (2D-SWE) techniques that use multiparametric approaches could bring essential improvements to diagnosis and risk stratification.

20 August 2021 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
DMDaniela Matei
Daniela Matei
Rares CraciunRares Craciun
Rares Craciun
DCDANA CRISAN
DANA CRISAN
BPBogdan Procopet
Bogdan Procopet
TMTudor Voicu Mocan
Tudor Voicu Mocan
Zeno SpârchezZeno Spârchez
Zeno Spârchez
Background: Hepatic hydrothorax (HH) is an understudied complication of decompensated cirrhosis. We aimed to evaluate the long-term prognosis of patients with HH by comparing them with a matched non-HH group. Methods: This retrospective study included 763 consecutive patients hospitalized for decompensated cirrhosis and ascites. Ninety-seven patients with HH were matched for survival analysis with non-HH patients based on liver disease severity. Results: The prevalence of HH was 13.1%. Patients with HH had significantly worse overall liver function. Upon matching, patients with HH had a lower long-term survival (15.4% vs. 30.9% at 5 years) with a mean overall survival of 22.2 ± 2.2 months for the HH group vs. 27.1 ± 2.6 months for the non-HH group (Log Rank–0.05). On multivariate survival analysis using Cox regression, the MELD-Na score, ALBI grade, hepato-renal syndrome, and grade III ascites had a significant impact on mortality in patients with HH. In patients with HH, a MELD-Na score ≥ 16, ALBI grade III, hepato-renal syndrome, or severe ascites delineated high-mortality risk groups. Conclusions: HH is consistently associated with more advanced liver disease. Patients with HH have worse long-term survival, their prognosis being closely intertwined with overlapping decompensating events.